These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31905933)

  • 1. Overexpression of Hepatocyte Chemerin-156 Lowers Tumor Burden in a Murine Model of Diethylnitrosamine-Induced Hepatocellular Carcinoma.
    Haberl EM; Pohl R; Rein-Fischboeck L; Feder S; Sinal CJ; Bruckmann A; Hoering M; Krautbauer S; Liebisch G; Buechler C
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemerin in a Mouse Model of Non-alcoholic Steatohepatitis and Hepatocarcinogenesis.
    Haberl EM; Pohl R; Rein-Fischboeck L; Feder S; Sinal CJ; Buechler C
    Anticancer Res; 2018 May; 38(5):2649-2657. PubMed ID: 29715085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemerin Isoform-Specific Effects on Hepatocyte Migration and Immune Cell Inflammation.
    Feder S; Bruckmann A; McMullen N; Sinal CJ; Buechler C
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte expressed chemerin-156 does not protect from experimental non-alcoholic steatohepatitis.
    Pohl R; Eichelberger L; Feder S; Haberl EM; Rein-Fischboeck L; McMullen N; Sinal CJ; Bruckmann A; Weiss TS; Beck M; Höring M; Krautbauer S; Liebisch G; Wiest R; Wanninger J; Buechler C
    Mol Cell Biochem; 2022 Aug; 477(8):2059-2071. PubMed ID: 35449483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation.
    Lin Y; Yang X; Liu W; Li B; Yin W; Shi Y; He R
    Oncogene; 2017 Jun; 36(25):3599-3608. PubMed ID: 28166197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
    Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
    Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
    Sun L; Beggs K; Borude P; Edwards G; Bhushan B; Walesky C; Roy N; Manley MW; Gunewardena S; O'Neil M; Li H; Apte U
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G91-G104. PubMed ID: 27151938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
    Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
    J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemerin causes lipid metabolic imbalance and induces passive lipid accumulation in human hepatoma cell line via the receptor GPR1.
    Zhu L; Huang J; Wang Y; Yang Z; Chen X
    Life Sci; 2021 Aug; 278():119530. PubMed ID: 33887347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell expression patterns of CD147 in N-diethylnitrosamine/phenobarbital-induced mouse hepatocellular carcinoma.
    Lu M; Wu J; He F; Wang XL; Li C; Chen ZN; Bian H
    J Mol Histol; 2015 Feb; 46(1):79-91. PubMed ID: 25447507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The involvement of iron in chemerin induced cell cycle arrest in human hepatic carcinoma SMMC7721 cells.
    Sun P; Wang S; Wang J; Sun J; Peng M; Shi P
    Metallomics; 2018 Jun; 10(6):838-845. PubMed ID: 29872820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
    Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
    Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokeratin 7/19 expression in N-diethylnitrosamine-induced mouse hepatocellular lesions: implications for histogenesis.
    Santos NP; Oliveira PA; Arantes-Rodrigues R; Faustino-Rocha AI; Colaço A; Lopes C; Gil da Costa RM
    Int J Exp Pathol; 2014 Jun; 95(3):191-8. PubMed ID: 24730441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitis.
    Pohl R; Haberl EM; Rein-Fischboeck L; Zimny S; Neumann M; Aslanidis C; Schacherer D; Krautbauer S; Eisinger K; Weiss TS; Buechler C
    Eur J Clin Invest; 2017 Jan; 47(1):7-18. PubMed ID: 27797398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of cholesterol, triglycerides and ceramides in hepatocellular carcinomas of diethylnitrosamine injected mice.
    Haberl EM; Pohl R; Rein-Fischboeck L; Höring M; Krautbauer S; Liebisch G; Buechler C
    Lipids Health Dis; 2021 Oct; 20(1):135. PubMed ID: 34629057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic chemerin and chemokine-like receptor 1 expression in patients with chronic hepatitis C.
    Kukla M; Adamek B; Waluga M; Zalewska-Ziob M; Kasperczyk J; Gabriel A; Mazur W; Sobala-Szczygieł B; Bułdak RJ; Zajęcki W; Kępa L; Ziora K; Żwirska-Korczala K; Wiczkowski A; Hartleb M
    Biomed Res Int; 2014; 2014():517820. PubMed ID: 25121101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic leptin receptor expression can partially compensate for IL-6Rα deficiency in DEN-induced hepatocellular carcinoma.
    Mittenbühler MJ; Sprenger HG; Gruber S; Wunderlich CM; Kern L; Brüning JC; Wunderlich FT
    Mol Metab; 2018 Nov; 17():122-133. PubMed ID: 30224299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
    Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
    Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic administration of diethylnitrosamine to induce hepatocarcinogenesis and to evaluate its synergistic effect with other hepatotoxins in mice.
    Fuentes-Hernández S; Alarcón-Sánchez BR; Guerrero-Escalera D; Montes-Aparicio AV; Castro-Gil MP; Idelfonso-García OG; Rosas-Madrigal S; Aparicio-Bautista DI; Pérez-Hernández JL; Reyes-Gordillo K; Lakshman MR; Vásquez-Garzón VR; Baltiérrez-Hoyos R; López-González ML; Sierra-Santoyo A; Villa-Treviño S; Pérez-Carreón JI; Arellanes-Robledo J
    Toxicol Appl Pharmacol; 2019 Sep; 378():114611. PubMed ID: 31176654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
    Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
    J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.